Short Interest in Nukkleus Inc. (NASDAQ:DFNS) Increases By 159.3%

Nukkleus Inc. (NASDAQ:DFNS) saw a large increase in short interest in the month of June. As of June 15th, there was short interest totaling 12,709,157 shares, an increase of 159.3% from the May 31st total of 4,901,184 shares. Approximately 27.1% of the shares of the company are short sold. Based on an average daily trading volume, of 38,610,141 shares, the short-interest ratio is currently 0.3 days.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Wall Street Zen cut Nukkleus from a “hold” rating to a “sell” rating in a research report on Saturday, April 18th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Nukkleus in a research report on Thursday, June 18th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Nukkleus presently has a consensus rating of “Sell”.

Institutional Trading of Nukkleus

Institutional investors have recently made changes to their positions in the business. GM Advisory Group LLC bought a new stake in Nukkleus in the fourth quarter valued at about $56,000. BNP Paribas Financial Markets bought a new position in Nukkleus during the second quarter worth about $56,000. Price T Rowe Associates Inc. MD acquired a new stake in Nukkleus during the fourth quarter valued at approximately $57,000. Millennium Management LLC acquired a new stake in Nukkleus during the fourth quarter valued at approximately $60,000. Finally, State Street Corp grew its stake in shares of Nukkleus by 70.7% in the 4th quarter. State Street Corp now owns 17,863 shares of the company’s stock valued at $72,000 after purchasing an additional 7,400 shares during the period. 12.47% of the stock is currently owned by institutional investors and hedge funds.

Key Nukkleus News

Here are the key news stories impacting Nukkleus this week:

• Positive Sentiment: Zacks Research’s longer-term forecast for Nukkleus turns profitable by FY2028-FY2030, with estimates of $0.01, $0.03, and $0.06 per share, which suggests analysts see a path to eventual earnings growth. Zacks Research EPS estimates for Nukkleus
• Neutral Sentiment: Zacks Research also issued near-term estimates showing continued losses in 2026, including Q2 at ($0.05), Q3 at ($0.04), and Q4 at ($0.03) per share, along with a FY2026 loss estimate of ($0.99) per share, reinforcing that profitability is still distant. Zacks Research EPS estimates for Nukkleus
• Negative Sentiment: Short interest rose sharply in mid-June to 12.7 million shares, with about 27.1% of the float sold short, signaling bearish sentiment and potential selling pressure on the stock. Short interest update for Nukkleus

Nukkleus Stock Performance

Shares of DFNS opened at $0.17 on Monday. The stock’s 50-day moving average price is $0.38 and its 200 day moving average price is $1.76. The company has a quick ratio of 0.21, a current ratio of 0.25 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $16.17 million, a price-to-earnings ratio of -0.06 and a beta of -6.00. Nukkleus has a 12-month low of $0.16 and a 12-month high of $15.59.

Nukkleus (NASDAQ:DFNS) last announced its quarterly earnings data on Wednesday, May 20th. The company reported ($1.14) EPS for the quarter. The business had revenue of $3.65 million during the quarter. As a group, research analysts predict that Nukkleus will post -0.99 earnings per share for the current year.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.